PNV OB+DHA Softgel By PharmaPure Rx Overview & Drug Interactions
Check For Interactions With PNV OB+DHA Softgel
Supplement: PNV OB+DHA Softgel by PharmaPure Rx
PNV OB+DHA Softgel Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Docosahexaenoic Acid
| Ingredient Group | DHA (Docosahexaenoic Acid) |
|---|---|
| Category | fatty acid |
Drugs that interact with PNV OB+DHA Softgel by PharmaPure Rx
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with PNV OB+DHA Softgel. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Softgel(s)
|
| Maximum serving Sizes: |
1 Softgel(s)
|
| UPC/BARCODE | 731477471771 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Docosahexaenoic Acid |
250 mg
|
DHA (Docosahexaenoic Acid) |
--
|
| Other Ingredients: |
Gelatin
Water
Glycerin
Polysorbate 80
|
|---|
Label Statments:
| Formula |
- 250 mg DHA Softgel
- Contains Stool Softener
- INDICATIONS: PNNV OB+DHA is a prescription regimen of prenatal multivitamin, multi-mineral and Omega-3 fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post-natal period for both lactating and non-lactating mothers.
- 30 Softgels: Docosahexaenoic Acid (DHA) 250 mg
- Each PNV OB+DHA softgel contains:
250 mg Docosahexaenoic Acid (DHA)
- May contain Vanillin.
- Also contains Eicosapentaenoic Acid (EPA) and other Omega-3 Fatty Acids.
- Contains Soy.
|
|---|---|
| FDA Statement of Identity |
- Dietary Supplement
|
| General Statements |
- 30-Day Supply
- PNV OB+DHA is also useful in improving the nutritional status prior to conception.
- Consult package insert for full prescribing information.
- Rx Only
- DHA is contained in the oil derived from fish (tuna).
- Cloudiness of the softgel is a characteristic of natural fish oil.
|
| Suggested/Recommended/Usage/Directions |
- DOSAGE AND ADMINISTRATION: Before, during and after pregnancy, one caplet and one softgel taken by mouth daily, or as directed by a physician. The caplet and softgel may be taken together or at different times of the day.
|
| Precautions |
- Caution should be exercised to ensure that the prescribed dose of DHA does not exceed 1 gram (1,000 mg) per day.
- Contains Soy.
|
| Seals/Symbols |
- PharmaPureRx
|
| General |
- List No. 11560 ENY Rev. 00-33265
|
Brand Information
| Manufactured by | |
|---|---|
| Name | PureTek Corporation |
| City | San Fernando |
| State | CA |
| ZipCode | 91340 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.